Ann Dahlberg, MD
Both of my parents are physicians. Listening to their stories over the years and watching the trajectory of their careers in medicine has always been an inspiration for me. During medical school, I developed an interest in the biology of the blood and immune systems and how we could apply that knowledge to finding long-term cures for high-risk diseases. Pediatric bone marrow transplantation allows me to combine my scientific interests with my love of working with children and their families. My approach to care is based on the belief that you know your child best, so your input is essential to treatment planning. I’m committed to using every tool in our toolbox in order to provide the best outcome possible. This includes relying on all the data we have at our fingertips, exploring clinical trial opportunities and making decisions that are patient-specific.
I know several people who have been affected by cancer. One person was treated here at SCCA, and I came with her on some of her visits. Her physician spent a lot of time with us. I was impressed with the way he had his pulse on her desires and wishes, creating a treatment plan that honored them while also helping her husband navigate the situation as a caregiver. Watching their interactions reinforced the significance of the words we choose. What we say as physicians has a lot of impact on patients; it has the power to instill hope.
Specialty: Medical Oncology
I am a board-certified hematologist-oncologist who specialize in pediatric bone marrow transplantation. I provide care for children with a variety of malignant and non-malignant diseases with a focus on patients who have leukemia. At Seattle Children’s, I also direct the Bone Marrow Transplantation Transition Clinic, which provides long-term follow-up care for children who have received a transplant to treat leukemia.
One of the most satisfying aspects of my career has been the ability to work closely with patients in the present while striving to improve the care we provide in the future. As a clinical researcher, I study cord blood transplantation. This form of transplant involves collecting blood-forming cells, known as stem cells, from the umbilical cord after a baby’s birth. These stem cells can be used in the treatment of leukemia and other life-threatening diseases. Another primary research interest is developing strategies to reduce the risk of leukemia relapse after a transplant.
We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.
Your care team
SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.